---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-031087"
form_type: "8-K"
ticker: "BBIO"
cik: "0001743881"
company_name: "BridgeBio Pharma, Inc."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:31:18.316182+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BridgeBio shareholders approve all proposals, including 6.5M share increase to equity plan

## Summary
- All five director nominees elected: Eric Aguiar, Jennifer Cook, Andrea Ellis, Fred Hassan, Ali Satvat.
- Advisory say-on-pay vote passed with ~134.3M for, ~9.3M against.
- Deloitte & Touche ratified as independent auditor for fiscal 2024.
- 2021 Stock Plan amended to increase shares reserved by 6.5 million.
- Broker non-votes were 17.3M on director election and most other proposals.

## SEC filing metadata
- accession: 0001140361-24-031087
- form_type: 8-K
- ticker: BBIO
- cik: 0001743881
- company_name: BridgeBio Pharma, Inc.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1743881/000114036124031087/0001140361-24-031087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1743881/000114036124031087/ef20031581_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-031087
- JSON: https://secwatch.observer/filing/0001140361-24-031087.json
- Plain text: https://secwatch.observer/filing/0001140361-24-031087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.